Type |
Event |
Symptoms |
Dx |
Treatment |
Prevention |
Acute -Febrile |
Hemolytic, immune (AHTR) |
Fever/chills Back pain Hemoglobinemia Hemoglobinuria Hypotension, renal failure Shock DIC |
DAT positive ↓ Hemoglobin ↑ LDH ↑ Bilirubin ↓ Haptoglobin |
Discontinue transfusion Maintain vascular access Maintain blood pressure Maintain renal blood flow Treat DIC if present |
Follow standard operating procedures for identification of the patient |
Acute –Febrile |
Hemolytic nonimmune (ANIHTR) |
Asymptomatic Hemoglobinuria |
DAT negative |
Discontinue transfusion Maintain vascular access Maintain renal blood flow |
Follow standard operating procedures for equipment operation |
Acute –Febrile |
Transfusion associated Sepsis (TAS) |
Fever/chills Hypotension Shock |
DAT negative
Gram stain blood bag Culture blood bag Culture patient |
Discontinue transfusion Maintain vascular access Consider initial broad-spectrum antibiotic coverage |
Follow standard operating procedures for collection Implement bacterial detection intervention prior to transfusion |
Acute –Febrile |
Febrile nonhemolytic (FNHTR) |
Fever/chills Nausea/vomiting Tachycardia Tachypnea ↑ Blood pressure |
DAT negative |
Treat with antipyretics For rigors, treat with meperidine |
Prestorage leukoreduction of PRBC and platelets |
Acute – Allergic |
Allergic, mild |
Erythema Pruritus |
Clinical diagnosis DAT not required |
Temporary discontinue transfusion Treat with antihistamines If symptoms improve restart transfusion |
For repeated reactions, consider premedication with antihistamines |
Acute – Allergic |
Severe anaphylaxis |
Angioedema Wheezing Hypotension Anaphylaxis |
DAT negative
IgA deficiency workup when indicated |
Discontinue transfusion Maintain vascular access Treat with subcutaneous epinephrine Maintain blood pressure Provide respiratory support |
For IgA absolute deficient patients provide IgA deficient blood components |
Acute – Pulmonary |
Transfusion Associated Circulatory Overload (TACO) |
Severe hypoxemia ↑ Blood pressure Jugular vein distension ↑ Central venous pressure |
CXR: pulmonary edema, cardiomegaly, distended pulmonary artery BNP |
Upright posture Supplemental oxygen Diuresis |
Slower transfusion rate Transfuse in smaller volumes |
Acute – Pulmonary |
Transfusion Related Acute Lung injury (TRALI) |
Severe hypoxemia No evidence of left atrial hypertension |
CXR: bilateral infiltrates Donor test for HLA/HNA antibodies Recipient test for HLA/HNA antigens |
Discontinue transfusion Maintain vascular access Supplemental oxygen Mechanical ventilation |
Use male only plasma Exclude or screen female platelet donors |
Acute – other |
Massive transfusion related |
|
|
|
|
Delayed |
Delayed hemolytic reaction (DSHTR) |
Asymptomatic Fatigue |
+ Antibody screen/DAT ↓ Hemoglobin |
As needed Transfuse antigen negative, AHG crossmatched compatible PRBC |
Accurate record-keeping Obtain transfusion history Limit transfusions |
Delayed |
Delayed Hemolytic Transfusion Reaction (DHTR) |
Flulike symptoms Pallor Jaundice |
↓ Hemoglobin ↑ Total bilirubin |
As needed Transfuse antigen negative, AHG crossmatched compatible PRBC |
Accurate record-keeping Obtain transfusion history Limit transfusions |
Delayed |
Transfusion Associated Graft Vs. Host Disease (TAGVHD) |
Rash Fever Diarrhea |
Pancytopenia Identify donor engraftment |
Not available |
Gamma irradiation of cellular blood components as indicated |
Delayed |
Post transfusion purpura |
Bleeding |
Thrombocytopenia HPA antibodies |
Intravenous immunoglobulin |
Limit transfusions |
Delayed |
Iron overload |
Multi-organ failure |
High ferritin levels |
Use of iron-chelating agents |
Prophylactic use of iron-chelating agents Red cell exchange |
Silent |
RBC allo-immunization |
|
|
|
|
Silent |
Platelet alloimmunization |
|
|
|
|
Special |
Plasma derivatives |
|
|
|
|
Special |
Therapeutic apheresis |
|
|
|
|
Special |
Neonatal |
|
|
|
|
Special |
Pediatric |
|
|
|
|
Special |
Autologous |
|
|
|
|